OraSure Technologies (OSUR) Stock Profit Return Faces Cash Flow Doubts

Simply Wall St.

Aug 08

OraSure Technologies stock barely budged after earnings, up just 1.25% to US$4.05. Yet the emotion around this quarter sits in a very different place from the recent history. You are looking at a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2657624492"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2657624492\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2657624492?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","is_english":true,"pubTime":"2026-08-08 07:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657624492","market":"sg","top_or_hot":-1,"title":"OraSure Technologies (OSUR) Stock Profit Return Faces Cash Flow Doubts","media":"Simply Wall St.","content":"<div>\n<p>OraSure Technologies stock barely budged after earnings, up just 1.25% to US$4.05. Yet the emotion around this quarter sits in a very different place from the recent history. You are looking at a ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-osur/orasure-technologies/news/orasure-technologies-osur-stock-profit-return-faces-cash-flo\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OraSure Technologies (OSUR) Stock Profit Return Faces Cash Flow Doubts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOraSure Technologies (OSUR) Stock Profit Return Faces Cash Flow Doubts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-08 07:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-osur/orasure-technologies/news/orasure-technologies-osur-stock-profit-return-faces-cash-flo><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>OraSure Technologies stock barely budged after earnings, up just 1.25% to US$4.05. Yet the emotion around this quarter sits in a very different place from the recent history. You are looking at a ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-osur/orasure-technologies/news/orasure-technologies-osur-stock-profit-return-faces-cash-flo\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VOTE","symbol_name":"TCW Transform 500 ETF","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-osur/orasure-technologies/news/orasure-technologies-osur-stock-profit-return-faces-cash-flo","article_id":"2657624492","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-osur/orasure-technologies/news/orasure-technologies-osur-stock-profit-return-faces-cash-flo","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2657624492","pubTimestamp":1786146730,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"OraSure Technologies stock barely budged after earnings, up just 1.25% to US$4.05. Yet the emotion around this quarter sits in a very different place from the recent history. You are looking at a company that just swung from deep quarterly losses to a positive basic earnings per share of US$0.09 while lifting revenue to US$30.6 million. For a diagnostics and sample management specialist that has been wrestling with red ink, a profitable quarter and expanding gross margin are the real...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"VOTE":"TCW Transform 500 ETF","VGFPF":"Vanguard Funds PLC","GXDW":"Global X Dorsey Wright Thematic ETF","RGLO":"Global Equity Active ETF","DECU":"AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF","JOYT":"JPMorgan Equity and Options Total Return ETF","BK4588":"碎股","FEBU":"AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF","BK4198":"医疗保健用品","SPHQ":"Invesco S&P 500 Quality ETF","BK4585":"ETF&股票定投概念","OSUR":"奥瑞许科技","PMDE":"PGIM S&P 500 Max Buffer ETF - December"},"translate_title":"OraSure Technologies (OSUR) 股票利润回报面临现金流疑虑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GXDW":0.76,"VOTE":0.76,"PMDE":0.76,"DECU":0.76,"SPHQ":0.66,"RGLO":0.76,"VGFPF":0.76,"OSUR":1.5,"JOYT":0.76,"FEBU":0.76},"content_text":"OraSure Technologies stock barely budged after earnings, up just 1.25% to US$4.05. Yet the emotion around this quarter sits in a very different place from the recent history. You are looking at a company that just swung from deep quarterly losses to a positive basic earnings per share of US$0.09 while lifting revenue to US$30.6 million. For a diagnostics and sample management specialist that has been wrestling with red ink, a profitable quarter and expanding gross margin are the real headline, even if the share price reaction suggests investors are not fully buying the shift yet. Impressed by OraSure Technologies swinging to a profit but unsure how repeatable that kind of turnaround is for a diagnostics stock? If you want a broader benchmark of companies pairing cleaner earnings profiles with balance sheet strength, take a look at our list of solid balance sheet and fundamentals stocks (49 results). AdvertisementQ2 2026 Earnings Summary  Revenue (Q2 2026 vs. Q2 2025) US$30.64 million vs. US$31.24 million (slight decline year on year) Net Income (Q2 2026 vs. Q2 2025) profit of US$6.25 million vs. loss of US$19.69 million (moved from loss to profit) Basic EPS (Q2 2026 vs. Q2 2025) US$0.09 vs. loss of US$0.26 per share (returned to positive earnings per share) Total Revenue, Trailing Twelve Months to Q2 2026 vs. TTM to Q2 2025 US$112.41 million vs. US$138.53 million (decline in trailing twelve month revenue)  Prefer clean, visual charts instead of scrolling through dense earnings tables and footnotes? See OraSure Technologies' full financial picture, with a focus on its recent profitability shift, in our company report for OraSure Technologies. NasdaqGS:OSUR Trailing 12-Month Earnings & Revenue History as at Aug 2026 OraSure bullish story hinges on margins and new launches Optimists argue OraSure Technologies is turning product launches and manufacturing insourcing into a cleaner, self funded growth story. The latest quarter gives some support. Revenue of US$30.6 million came in above guidance and grew sequentially, with Diagnostics and Sample Management Solutions both higher on that basis. GAAP gross margin improved to 43.5%, helped by lower scrap and operational efficiencies, which backs the idea that internal manufacturing is starting to work. GAAP operating income of US$5.4 million and a swing to positive EPS also point to better cost control. New products are moving from slide decks into the field. Colli Pee Dx secured FDA clearance for use with Roche Cobas STI testing and Ebola 2.0 received Emergency Use Authorization. Management is still targeting operating cash flow breakeven as the company enters 2027, which keeps the self funding narrative alive. Bear case focuses on revenue quality and execution risk Skeptics worry that OraSure is too exposed to lumpy funding, a few key programs, and slow product rollouts. The numbers give that view some backing. Trailing twelve month revenue of US$112.4 million is below the prior year, even as Q2 inflected to profit, which suggests the improvement is still early. Operating cash flow was a use of US$9.9 million in the quarter, so the business is not yet funding itself despite GAAP profitability. Management also withdrew the InteliQuick CT/NG submission, which pushes out a high profile U.S. launch with no new timeline. Guidance of US$29.5 million to US$32.5 million for Q3 and gross margin roughly similar to Q2 points to a steady rather than sharp step up. Elevated G&A from proxy and legal costs is expected to ease, but it showed how quickly overhead can pressure results if one off items appear. After withdrawn submissions, uneven funding and earnings forecasts pointing lower, you might ask what else is lurking. Review our risk analysis for OraSure Technologies which shows 1 important warning sign. Stay Ahead With Simply Wall St If OraSure Technologies swinging to a quarterly profit has your attention but you are waiting for a clearer entry point, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value before committing capital. After you own any stock, use the Portfolio Command Center to cut through noise and focus on earnings, valuation and balance sheet changes that matter to your holdings. For a longer term view, tap into crowd insights and discussion through the Community to see how other investors are interpreting the same data. This combination helps you surface potential catalysts or red flags early and stay ahead of the broader market. Seeking Alternatives Beyond OraSure Technologies? Fresh ideas do not stay under the radar for long. Spot stocks building real momentum before the crowd catches on and the best entry points start dropping away. Act now.  Track cash rich companies that can fund growth from their own balance sheets by reviewing a curated list of solid balance sheet and fundamentals stocks (49 results) while that financial strength is still overlooked. Ride the next wave of AI fueled earnings stories by scanning 68 profitable AI stocks that aren't just burning cash before fast moving headlines pull these opportunities out of the quiet accumulation phase. Position for potential upside from a structural shift in energy by checking 89 nuclear energy infrastructure stocks while many investors remain focused on yesterday's power technologies.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}